(19)
(11) EP 4 572 780 A2

(12)

(88) Date of publication A3:
25.04.2024

(43) Date of publication:
25.06.2025 Bulletin 2025/26

(21) Application number: 23855592.4

(22) Date of filing: 14.08.2023
(51) International Patent Classification (IPC): 
A61K 38/17(2006.01)
A61K 38/03(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 14/47; A61K 2039/55505; A61K 2039/57; A61K 2039/70; A61K 39/0005
(86) International application number:
PCT/US2023/072164
(87) International publication number:
WO 2024/040025 (22.02.2024 Gazette 2024/08)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 19.08.2022 US 202263371999 P

(71) Applicant: University of Washington
Seattle, WA 98195 (US)

(72) Inventors:
  • DISIS, Mary L.
    SEATTLE, Washington 98105-4721 (US)
  • CECIL, Denise
    SEATTLE, Washington 98105-4721 (US)
  • CORULLI, Lauren
    SEATTLE, Washington 98105-4721 (US)

(74) Representative: FRKelly 
Waterways House Grand Canal Quay
Dublin D02 PD39
Dublin D02 PD39 (IE)

   


(54) TH2 VACCINE-BASED PREVENTION AND TREATMENT OF INFLAMMATION IN OBESITY